Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Insiders arent even buying at these prices
View:
Post by Stutters on Mar 11, 2022 1:52pm

Insiders arent even buying at these prices

none are interested. Most of us have more shares than the directors lol.
Comment by MrMugsy on Mar 11, 2022 5:20pm
hahaha - don't think you have more than any director ... or even more than any one employee (for that matter).  Nice try though.
Comment by StockingUp21 on Mar 11, 2022 5:50pm
Gift shares doesnt count muggy. They don't spend personal money on this garbage. I don't blame them
Comment by MrMugsy on Mar 12, 2022 12:42pm
You just keep focusing on people - the real investors will focus on value and competitive advantage. You focus on who an alias might be - we'll focus on the science, the IP and the value of future IP. You focus on your paper losses and stay angry - we'll focus on the funnel, the next opportunity and the real value of H2S as a gaseous mediator. It's fun to watch !!! ---------------- ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities